Manufacturers Mentor and Sientra did not adequately comply with post-approval study requirements that look at the long-term safety and risks of silicone implants.
Infusion pump companies are perpetuating misconceptions.
The center will start phasing in efficiencies on March 18.
The strategic acquisitions expand the company’s structural heart disease technologies.
The resignation will be effective in about a month, according to reports.
The regulation is bringing digital enablement to the forefront, requiring electronic instructions for use.
According to the FDA, more than 90% of products sterilized at the facility are medical devices.
Despite pricing pressures, several sectors within the medical device industry can expect to enjoy growth and attract attention from investors.
The deal will help J&J speed up its entry into the robotics market.
The deal will help strengthen the Edwards portfolio of smart monitoring technologies.